Loading clinical trials...
Loading clinical trials...
Cannabis use disorders remain a significant public health problem. The pharmacological facilitation of behavioral treatment represents a promising strategy for addressing disordered cannabis use. Cann...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
New York State Psychiatric Institute
Collaborators
NCT07160153 · Cannabis Dependence, Harmful Use, and more
NCT01730781 · Schizophrenia, Cannabis Dependence, and more
NCT04721353 · Cannabis Dependence, Posttraumatic Stress Disorder, and more
NCT03204305 · Cannabis Use Disorder, Cannabis Dependence, Continuous
NCT03221231 · Cannabis Use Disorder, Cannabis Dependence
NYSPI
New York, New York
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions